Cargando…

Treatment response and several patient-reported outcomes are early determinants of future self-efficacy in rheumatoid arthritis

BACKGROUND: Self-efficacy, or patients’ confidence in their ability to control disease and its consequences, was recently prioritised in EULAR recommendations for inflammatory arthritis self-management strategies. However, it remains unclear which factors influence self-efficacy in early rheumatoid...

Descripción completa

Detalles Bibliográficos
Autores principales:	Michaël, Doumen, Diederik, De Cock, Sofia, Pazmino, Delphine, Bertrand, Johan, Joly, René, Westhovens, Patrick, Verschueren
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8549201/ https://www.ncbi.nlm.nih.gov/pubmed/34706771 http://dx.doi.org/10.1186/s13075-021-02651-3

Ejemplares similares

Correction to: Treatment response and several patient-reported outcomes are early determinants of future self-efficacy in rheumatoid arthritis
por: Doumen, Michaël, et al.
Publicado: (2021)

Effectiveness and feasibility of a mobile health self-management intervention in rheumatoid arthritis: study protocol for a pragmatic multicentre randomised controlled trial (AEGORA)
por: Doumen, Michaël, et al.
Publicado: (2023)

The ideal mHealth-application for rheumatoid arthritis: qualitative findings from stakeholder focus groups
por: Doumen, Michaël, et al.
Publicado: (2021)

Short-term glucocorticoids reduce risk of chronic NSAID and analgesic use in early methotrexate-treated rheumatoid arthritis patients with favourable prognosis: subanalysis of the CareRA randomised controlled trial
por: Pazmino, Sofia, et al.
Publicado: (2021)

Engagement and attrition with eHealth tools for remote monitoring in chronic arthritis: a systematic review and meta-analysis
por: Doumen, Michaël, et al.
Publicado: (2022)

The perception of stakeholders on the applicability of nurse-led clinics in the management of rheumatoid arthritis
por: Doumen, Michaël, et al.
Publicado: (2021)

One in five patients with rapidly and persistently controlled early rheumatoid arthritis report poor well-being after 1 year of treatment
por: Van der Elst, Kristien, et al.
Publicado: (2020)

Comorbidity burden in the first three years after diagnosis in patients with rheumatoid arthritis, psoriatic arthritis or spondyloarthritis: a general practice registry-based study
por: Stouten, Veerle, et al.
Publicado: (2021)

An exploration of the relative importance of barriers hindering intensive combination treatment strategies in early rheumatoid arthritis
por: Meyfroidt, Sabrina, et al.
Publicado: (2014)

The perspective of patients with early rheumatoid arthritis on the journey from symptom onset until referral to a rheumatologist
por: De Cock, Diederik, et al.
Publicado: (2019)

Patients’ experiences with intensive combination treatment strategies for early rheumatoid arthritis: a longitudinal qualitative study embedded in the carera trial
por: Meyfroidt, Sabrina, et al.
Publicado: (2014)

‘More than just chitchat’: a qualitative study concerning the need and potential format of a peer mentor programme for patients with early rheumatoid arthritis
por: Van der Elst, Kristien, et al.
Publicado: (2021)

JAK inhibition and the holy grail for pain control in early RA
por: Pazmino, Sofia, et al.
Publicado: (2022)

The Effect of Meditation, Mindfulness, and Yoga in Patients with Rheumatoid Arthritis
por: Slagter, Laura, et al.
Publicado: (2022)

Septic Arthritis Due to Staphylococcus Warneri: A Diagnostic Challenge
por: Legius, Barbara, et al.
Publicado: (2012)

Prevalence and associated factors of subclinical atherosclerosis in rheumatoid arthritis at the university hospital of Kinshasa
por: Mulumba, Christophe, et al.
Publicado: (2019)

Patients lacking classical poor prognostic markers might also benefit from a step-down glucocorticoid bridging scheme in early rheumatoid arthritis: week 16 results from the randomized multicenter CareRA trial
por: Verschueren, Patrick, et al.
Publicado: (2015)

Molecular imaging of rheumatoid arthritis: emerging markers, tools, and techniques
por: Put, Stéphanie, et al.
Publicado: (2014)

The phenotype and genotype of rheumatoid arthritis in the Democratic Republic of Congo
por: Malemba, JJ, et al.
Publicado: (2013)

Translating co-stimulation blockade into clinical practice
por: Westhovens, Rene, et al.
Publicado: (2008)

Biologic refractory disease in rheumatoid arthritis: results from the British Society for Rheumatology Biologics Register for Rheumatoid Arthritis
por: Kearsley-Fleet, Lianne, et al.
Publicado: (2018)

The Belgian MIRA (MabThera In Rheumatoid Arthritis) registry: clues for the optimization of rituximab treatment strategies
por: Vander Cruyssen, Bert, et al.
Publicado: (2010)

Response to the commentary 'Pooled indices to measure rheumatoid arthritis activity: a good reflection of the physician's mind'
por: Vander Cruyssen, Bert, et al.
Publicado: (2006)

Seven-year follow-up of infliximab therapy in rheumatoid arthritis patients with severe long-standing refractory disease: attrition rate and evolution of disease activity
por: Vander Cruyssen, Bert, et al.
Publicado: (2010)

Managing inadequate response to initial anti-TNF therapy in rheumatoid arthritis: optimising treatment outcomes
por: Taylor, Peter C., et al.
Publicado: (2022)

Self-Efficacy and Adherence Behaviors in Rheumatoid Arthritis Patients
por: Oshotse, Christiana, et al.
Publicado: (2018)

Identification of poor prognostic joint locations in an early rheumatoid arthritis cohort at risk of rapidly progressing disease: a post-hoc analysis of the Phase III AGREE study
por: Durez, Patrick, et al.
Publicado: (2022)

A Nationwide Survey on Patient’s versus Physician´s Evaluation of Biological Therapy in Rheumatoid Arthritis in Relation to Disease Activity and Route of Administration: The Be-Raise Study
por: De Mits, Sophie, et al.
Publicado: (2016)

Serious infection risk after 1 year between patients with rheumatoid arthritis treated with rituximab or with a second TNFi after initial TNFi failure: results from The British Society for Rheumatology Biologics Register for Rheumatoid Arthritis
por: Silva-Fernández, Lucía, et al.
Publicado: (2018)

Are genes the missing link to detect and prognosticate RA-ILD?
por: Vermant, Marie, et al.
Publicado: (2023)

Biologicals in rheumatoid arthritis: current and future
por: Avci, Ali Berkant, et al.
Publicado: (2015)

Future therapeutic targets in rheumatoid arthritis?
por: Cheung, Tommy Tsang, et al.
Publicado: (2017)

Efficacy and safety of filgotinib in methotrexate-naive patients with rheumatoid arthritis with poor prognostic factors: post hoc analysis of FINCH 3
por: Aletaha, Daniel, et al.
Publicado: (2021)

Effect of filgotinib, a selective JAK 1 inhibitor, with and without methotrexate in patients with rheumatoid arthritis: patient-reported outcomes
por: Genovese, Mark, et al.
Publicado: (2018)

Effect of Filgotinib on Body Mass Index (BMI) and Effect of Baseline BMI on the Efficacy and Safety of Filgotinib in Rheumatoid Arthritis
por: Balsa, Alejandro, et al.
Publicado: (2023)

The efficacy and safety of Tocilizumab in adults with refractory systemic onset JIA
por: Deslypere, G, et al.
Publicado: (2011)

Ultrasonographic Presentation and Anatomic Distribution of Lung Involvement in Patients with Rheumatoid Arthritis
por: Vermant, Marie, et al.
Publicado: (2023)

Effectiveness of TNF-inhibitors, abatacept, IL6-inhibitors and JAK-inhibitors in 31 846 patients with rheumatoid arthritis in 19 registers from the ‘JAK-pot’ collaboration
por: Lauper, Kim, et al.
Publicado: (2022)

Clinical efficacy of new JAK inhibitors under development. Just more of the same?
por: Westhovens, Rene
Publicado: (2019)

Attainment and characteristics of clinical remission according to the new ACR-EULAR criteria in abatacept-treated patients with early rheumatoid arthritis: new analyses from the Abatacept study to Gauge Remission and joint damage progression in methotrexate (MTX)-naive patients with Early Erosive rheumatoid arthritis (AGREE)
por: Smolen, Josef S., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_c5tvc0fn87irg320e5vs9du60a